Fig. 1 · Structure

Documents & Downloads

Tipranavir

Cat. No. A15262 CAS 174484-41-4

HIV protease inhibitor

Tipranavir, a nonpeptidic HIV protease inhibitor (NPPI), inhibits the enzymatic activity and dimerization of HIV-1 protease, exerts potent activity against multi-PI-resistant HIV-1 isolates.

In Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Biological Activity

Cellular Effect

Cell Line Activity Value Description Reference
H9 IC50 0.03 μM Inhibition of HIV-1 protease in a cell culture assay using HIV-1 IIIB infected H9 cells. [PMID: 9719600]
MT2 EC50 0.17 μM Antiviral activity against HIV1 LAI infected in human MT2 cells by MTT assay [PMID: 20439612]
MT2 EC50 0.3 μM Antiviral activity against HIV2 EHO infected in human MT2 cells by MTT assay [PMID: 20439612]
MT2 EC50 0.33 μM Antiviral activity against HIV2 ROD infected in human MT2 cells by MTT assay [PMID: 20439612]
MT2 CC50 54.1 μM Cytotoxicity against human MT2 cells after 7 days by MTT assay [PMID: 20439612]
MT4 EC50 0.022 μM Antiviral activity against HIV1 expressing protease L10I/G48V/I54V/A71V/I84V/L90M mutant infected in human MT4 cells selected at 5 uM of saquinavir by MTT assay [PMID: 20439612]
MT4 EC50 0.029 μM Antiviral activity against HIV1 expressing protease L10I/L24I/M46I/V82I/I84V mutant infected in human MT4 cells selected after 50 passages of GRL-216 by MTT assay [PMID: 20439612]
MT4 EC50 0.037 μM Antiviral activity against HIV1 expressing protease L10F/M46L/I50V/A71Vmutant infected in human MT4 cells selected at 1 uM of GRL-286 by MTT assay [PMID: 20439612]
MT4 EC50 0.039 μM Antiviral activity against HIV1 expressing protease L10F/D30N/K45I/A71V/T74S mutant infected in human MT4 cells selected at 5 uM of nelfinavir by MTT assay [PMID: 20439612]
MT4 EC50 0.042 μM Antiviral activity against HIV1 expressing protease L10F/M46M,I/Q61Q mutant infected in human MT4 cells selected at 1 uM of GRL-396 by MTT assay [PMID: 20439612]
MT4 EC50 0.095 μM Antiviral activity against HIV1 expressing protease L10F/M46I/T91S mutant infected in human MT4 cells selected at 1 uM of GRL-246 by MTT assay [PMID: 20439612]
MT4 EC50 0.22 μM Antiviral activity against HIV1 expressing protease L10F/M46I/I50V/A71V/I84V/L90M mutant infected in human MT4 cells selected at 5 uM of amprenavir by MTT assay [PMID: 20439612]
MT4 EC50 0.31 μM Antiviral activity against HIV1 expressing protease L10F/M46I/I54V/V82A mutant infected in human MT4 cells selected at 5 uM of Lopinavir by MTT assay [PMID: 20439612]
MT4 EC50 0.32 μM Antiviral activity against wild type HIV1 NL4-3 infected in human MT4 cells by MTT assay [PMID: 20439612]
MT4 EC50 0.41 μM Antiviral activity against HIV1 expressing protease L23I/E34Q/K43I/M46I/I50L/G51A/L63P/A71V/V82A/T91A mutant infected in human MT4 cells selected at 5 uM of atazanavir by MTT assay [PMID: 20439612]
MT4 EC50 184 nM Antiviral activity against wild-type HIV1 pNL4-3 infected in human MT4 cells assessed as reduction in viral cytopathogenicity treated 1 hr post infection measured 5 days post infection in absence of human serum by MTT assay [PMID: 18212102]
MT4 EC50 204 nM Antiviral activity against wild-type HIV1 RF infected in human MT4 cells assessed as reduction in viral cytopathogenicity treated 1 hr post infection measured 5 days post infection in absence of human serum by MTT assay [PMID: 18212102]
MT4 EC50 310 nM Antiviral activity against HIV1 HXB2 in human MT4 cells assessed as inhibition of viral-induced viral cytopathic effect in presence of 10% fetal bovine serum and 10% human serum by MTS assay [PMID: 17620375]
MT4 EC50 360 nM Antiviral activity against HIV1 A17 infected in human MT4 cells harboring protease L10F, V32I, M46I, I47V, Q58E, and I84V mutation derived from viral passages with Lopinavir assessed as reduction in viral cytopathogenicity treated 1 hr post infection meas [PMID: 18212102]

19 records · Scroll to view more

Specifications

Manufacturer Adooq Bioscience
Actions Inhibitor
CAS Number 174484-41-4
Applications HIV protease inhibitor
Formula C31H33F3N2O5S
Molecular Weight 602.66
SMILES
CCCC1(CC(=C(C(=O)O1)C(CC)C2=CC(=CC=C2)NS(=O)(=O)C3=NC=C(C=C3)C(F)(F)F)O)CCC4=CC=CC=C4

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Added to your cart

View Cart Checkout
Loading...